Book contents
- Genome Editing and Engineering
- Genome Editing and Engineering
- Copyright page
- Dedication
- Contents
- Contributors
- Foreword
- Preface
- Part I Biology of Endonucleases (Zinc-Finger Nuclease, TALENs and CRISPRs) and Regulatory Networks
- Part II Genome Editing in Model Organisms
- 5 Genome Editing in the Crustacean Daphnia magna using CRISPR/Cas and TALEN Systems
- 6 Leapfrogging: A Method for Targeting Genome Editing to the Germline
- 7 Genome Editing with Desired Mutations (Knockin) with CRISPR in Model Organisms
- 8 Genetically Engineered Pig Models for Human Diseases using ZFNs, TALENs and CRISPR/Cas9
- 9 Gene Editing to Create Agricultural and Biomedical Swine Models
- 10 Generation of New Model Cell Lines using ssODN Knockin Donors and FACS-based Genome Editing
- Part III Technology Development and Screening
- Part IV Genome Editing in Stem Cells and Regenerative Biology
- Part V Genome Editing in Disease Biology
- Part VI Legal (Intellectual Property) and Bioethical Issues of Genome Editing
- Index
- Plate Section (PDF Only)
- References
7 - Genome Editing with Desired Mutations (Knockin) with CRISPR in Model Organisms
from Part II - Genome Editing in Model Organisms
Published online by Cambridge University Press: 30 July 2018
Book contents
- Genome Editing and Engineering
- Genome Editing and Engineering
- Copyright page
- Dedication
- Contents
- Contributors
- Foreword
- Preface
- Part I Biology of Endonucleases (Zinc-Finger Nuclease, TALENs and CRISPRs) and Regulatory Networks
- Part II Genome Editing in Model Organisms
- 5 Genome Editing in the Crustacean Daphnia magna using CRISPR/Cas and TALEN Systems
- 6 Leapfrogging: A Method for Targeting Genome Editing to the Germline
- 7 Genome Editing with Desired Mutations (Knockin) with CRISPR in Model Organisms
- 8 Genetically Engineered Pig Models for Human Diseases using ZFNs, TALENs and CRISPR/Cas9
- 9 Gene Editing to Create Agricultural and Biomedical Swine Models
- 10 Generation of New Model Cell Lines using ssODN Knockin Donors and FACS-based Genome Editing
- Part III Technology Development and Screening
- Part IV Genome Editing in Stem Cells and Regenerative Biology
- Part V Genome Editing in Disease Biology
- Part VI Legal (Intellectual Property) and Bioethical Issues of Genome Editing
- Index
- Plate Section (PDF Only)
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Genome Editing and EngineeringFrom TALENs, ZFNs and CRISPRs to Molecular Surgery, pp. 97 - 109Publisher: Cambridge University PressPrint publication year: 2018
References
Auer, TO, Duroure, K, De Cian, A, Concordet, J-P, Del Bene, F. 2014. Highly efficient CRISPR/Cas9-mediated knock-in in zebrafish by homology-independent DNA repair. Genome Res 24(1): 142–153.CrossRefGoogle ScholarPubMed
Chari, R, Mali, P, Moosburner, M, Church, GM. 2015. Unraveling CRISPR-Cas9 genome engineering parameters via a library-on-library approach. Nat Methods 12(9): 823–826.CrossRefGoogle Scholar
Chen, F, Pruett-Miller, SM, Huang, Y, et al. 2011a. High-frequency genome editing using ssDNA oligonucleotides with zinc-finger nucleases. Nat Methods 8(9): 753–755.CrossRefGoogle ScholarPubMed
Chen, F, Pruett-Miller, SM, Huang, Y, et al. 2011b. High-frequency genome editing using ssDNA oligonucleotides with zinc-finger nucleases. Nat Methods 8(9): 753–755.CrossRefGoogle ScholarPubMed
Chen, Y, Cao, J, Xiong, M, et al. 2015. Engineering human stem cell lines with inducible gene knockout using CRISPR/Cas9. Cell Stem Cell 17(2): 233–244.CrossRefGoogle ScholarPubMed
Chu, VT, Weber, T, Wefers, B, et al. 2015. Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells. Nat Biotechnol 33(5): 543–548.CrossRefGoogle ScholarPubMed
Dickinson, DJ, Pani, AM, Heppert, JK, Higgins, CD, Goldstein, B. 2015. Streamlined genome engineering with a self-excising drug selection cassette. Genetics 200(4): 1035–1049.CrossRefGoogle ScholarPubMed
Doench, JG, Hartenian, E, Graham, DB, et al. 2014. Rational design of highly active sgRNAs for CRISPR-Cas9–mediated gene inactivation. Nat Biotechnol 32(12): 1262–1267.CrossRefGoogle ScholarPubMed
Dow, LE, Fisher, J, O’Rourke, KP, et al. 2015. Inducible in vivo genome editing with CRISPR-Cas9. Nat Biotechnol 33(4): 390–394.CrossRefGoogle ScholarPubMed
Duda, K, Lonowski, LA, Kofoed-Nielsen, M, et al. 2014. High-efficiency genome editing via 2A-coupled co-expression of fluorescent proteins and zinc finger nucleases or CRISPR/Cas9 nickase pairs. Nucl Acids Res 42(10): e84.CrossRefGoogle ScholarPubMed
Farboud, B, Meyer, BJ. 2015. Dramatic enhancement of genome editing by CRISPR/Cas9 through improved guide RNA design. Genetics 199(4): 959–971.CrossRefGoogle ScholarPubMed
Flemr, M, Bühler, M. 2015. Single-step generation of conditional knockout mouse embryonic stem cells. Cell Rep 12(4): 709–716.CrossRefGoogle ScholarPubMed
González, F, Zhu, Z, Shi, Z-D, et al. 2014. An iCRISPR platform for rapid, multiplexable, and inducible genome editing in human pluripotent stem cells. Cell Stem Cell 15(2): 215–226.CrossRefGoogle ScholarPubMed
Haeussler, M, Schönig, K, Eckert, H, et al. 2016. Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR. Genome Biol 17(1): 148.CrossRefGoogle ScholarPubMed
Hatada, S, Subramanian, A, Mandefro, B, et al. 2015. Low-dose irradiation enhances gene targeting in human pluripotent stem cells. Stem Cells Trans Med 4(9): 998–1010.CrossRefGoogle ScholarPubMed
He, X, Tan, C, Wang, F, et al. 2016. Knock-in of large reporter genes in human cells via CRISPR/Cas9-induced homology-dependent and independent DNA repair. Nucleic Acids Res 44(9): e85.CrossRefGoogle ScholarPubMed
Hisano, Y, Sakuma, T, Nakade, S, et al. 2015. Precise in-frame integration of exogenous DNA mediated by CRISPR/Cas9 system in zebrafish. Scientific Rep 5: 8841.CrossRefGoogle ScholarPubMed
Hwang, WY, Fu, Y, Reyon, D, et al. 2013. Heritable and precise zebrafish genome editing using a CRISPR-Cas system. PLoS One 8(7): e68708.CrossRefGoogle ScholarPubMed
Kleinstiver, BP, Tsai, SQ, Prew, MS, et al. (2016). Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells. Nat Biotechnol 34(8): 869–874.CrossRefGoogle ScholarPubMed
Li, J, Zhang, B-B, Ren, Y-G, et al. 2015. Intron targeting-mediated and endogenous gene integrity-maintaining knockin in zebrafish using the CRISPR/Cas9 system. Cell Res 25(5): 634–637.CrossRefGoogle ScholarPubMed
Liu, X, Homma, A, Sayadi, J, et al. 2016. Sequence features associated with the cleavage efficiency of CRISPR/Cas9 system. Scientific Rep 6: 19675.CrossRefGoogle ScholarPubMed
Maruyama, T, Dougan, SK, Truttmann, MC, et al. 2015. Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining. Nat Biotechnol 33(5): 538–542.CrossRefGoogle ScholarPubMed
Merkle, FT, Neuhausser, WM, Santos, D, et al. 2015. Efficient CRISPR-Cas9-mediated generation of knockin human pluripotent stem cells lacking undesired mutations at the targeted locus. Cell Rep 11(6): 875–883.CrossRefGoogle ScholarPubMed
Paquet, D, Kwart, D, Chen, A, et al. 2016. Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9. Nature 533(7601): 125–129.CrossRefGoogle ScholarPubMed
Park, A, Won, ST, Pentecost, M, Bartkowski, W, Lee, B. 2014. CRISPR/Cas9 allows efficient and complete knock-in of a destabilization domain-tagged essential protein in a human cell line, allowing rapid knockdown of protein function. PLoS One 9(4): e95101.CrossRefGoogle Scholar
Petrezselyova, S, Kinsky, S, Truban, D, et al. 2015. Homology arms of targeting vectors for gene insertions and CRISPR/Cas9 technology: size does not matter; quality control of targeted clones does. Cell Mol Biol Lett 20(5): 773–787.CrossRefGoogle ScholarPubMed
Pinder, J, Salsman, J, Dellaire, G. 2015. Nuclear domain “knock-in” screen for the evaluation and identification of small molecule enhancers of CRISPR-based genome editing. Nucleic Acids Res 43(19): 9379–9392.CrossRefGoogle ScholarPubMed
Platt, RJ, Chen, S, Zhou, Y, et al. 2014. CRISPR-Cas9 knockin mice for genome editing and cancer modeling. Cell 159(2): 440–455.CrossRefGoogle ScholarPubMed
Renaud, J-B, Boix, C, Charpentier, M, et al. 2016. Improved genome editing efficiency and flexibility using modified oligonucleotides with TALEN and CRISPR-Cas9 nucleases. Cell Rep 14(9): 2263–2272.CrossRefGoogle ScholarPubMed
Richardson, CD, Ray, GJ, DeWitt, MA, Curie, GL, Corn, JE. 2016. Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA. Nat Biotechnol 34(3): 339–344.CrossRefGoogle ScholarPubMed
Song, J, Yang, D, Xu, J, et al. 2016. RS-1 enhances CRISPR/Cas9- and TALEN-mediated knock-in efficiency. Nat Comm 7: 10548.CrossRefGoogle ScholarPubMed
Yang, L, Guell, M, Byrne, S, et al. 2013. Optimization of scarless human stem cell genome editing. Nucleic Acids Res 41(19): 9049–9061.CrossRefGoogle ScholarPubMed
Yoshimi, K, Kaneko, T, Voigt, B, Mashimo, T. 2014. Allele-specific genome editing and correction of disease-associated phenotypes in rats using the CRISPR–Cas platform. Nat Comm 5: 4240.CrossRefGoogle ScholarPubMed
Zetsche, B, Gootenberg, JS, Abudayyeh, OO, et al. 2015. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell 163(3): 759–771.CrossRefGoogle ScholarPubMed
Zhu, Z, Verma, N, González, F, Shi, Z-D, Huangfu, D. 2015. A CRISPR/Cas-mediated selection-free knockin strategy in human embryonic stem cells. Stem Cell Rep 4(6): 1103–1111.CrossRefGoogle ScholarPubMed